COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study

Hikmat Abdel‐Razeq, Baha’ Sharaf, Mohammed Al‐Jaghbeer, Hala Abu‐Fares, Rayan Bater, Moataz Abu Shaer, Hala Abu-Jaish, Dima Abu Laban, Osama Salamah, Faris Tamimi, Khalid Ashouri, Tareq Salameh, Raed Zughul, Yazan Alhalaseh